A multinational SWAY survey is shedding light on disparities and commonalities in symptoms, complications, and quality of life among patients with sickle cell disease (SCD) across sub-Saharan Africa (SSA), low- and middle-income countries (LMICs), and high-income countries (HICs).1
The findings suggest that individuals in SSA experience a higher frequency of severe vaso-occlusive crises despite being younger and having more limited access to pain management and supportive therapies, underscoring persistent global gaps in care.1